Private Capital Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$5K Sell
169
-53
-24% -$1.52K ﹤0.01% 1231
2022
Q1
$7K Buy
222
+72
+48% +$2.32K ﹤0.01% 1378
2021
Q4
$5K Sell
150
-13
-8% -$420 ﹤0.01% 1533
2021
Q3
$5K Buy
163
+134
+462% +$4.55K ﹤0.01% 1558
2021
Q2
$1K Hold
29
﹤0.01% 1943
2021
Q1
$1K Hold
29
﹤0.01% 1844
2020
Q4
$1K Hold
29
﹤0.01% 1865
2020
Q3
$1K Hold
29
﹤0.01% 1808
2020
Q2
$1K Hold
29
﹤0.01% 1795
2020
Q1
$1K Sell
29
-48
-62% -$1.43K ﹤0.01% 1759
2019
Q4
$2K Hold
77
﹤0.01% 1675
2019
Q3
$3K Hold
77
﹤0.01% 1789
2019
Q2
$4K Hold
77
﹤0.01% 1687
2019
Q1
$3K Hold
77
﹤0.01% 1782
2018
Q4
$3K Hold
77
﹤0.01% 1750
2018
Q3
$5K Hold
77
﹤0.01% 1689
2018
Q2
$4K Hold
77
﹤0.01% 1695
2018
Q1
$4K Sell
77
-197
-72% -$9.35K ﹤0.01% 1652
2017
Q4
$5 Buy
+274
New +$12.6K ﹤0.01% 1620

Other funds holding AVNS

Private Capital Group's AVNS Position: Q2 2022 in Review

Private Capital Group reduced its Avanos Medical (AVNS) stake by 24% in Q2 2022, selling an estimated $1.52K and leaving 169 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Private Capital Group first reported a position in AVNS in Q4 2017 and has held it in 19 quarters since. The position peaked at $7K in Q1 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Private Capital Group held 169 shares of Avanos Medical worth $5K as of Q2 2022.
  • Private Capital Group sold 53 Avanos Medical shares in Q2 2022, an estimated $1.52K.
  • Avanos Medical made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1231 holding.
  • Private Capital Group first reported a position in Avanos Medical in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Avanos Medical position peaked at $7K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.